Milestone Scientific Inc. MLSS
We take great care to ensure that the data presented and summarized in this overview for MILESTONE SCIENTIFIC INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MLSS
View all-
Vanguard Group Inc Valley Forge, PA2.15MShares$1.61 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA513KShares$384,8760.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX502KShares$376,2750.01% of portfolio
-
Swisspartners Ltd. Vaduz, N2252KShares$188,8740.15% of portfolio
-
Carnegie Capital Asset Management, LLC145KShares$108,8970.0% of portfolio
-
Mariner, LLC Overland Park, KS122KShares$91,3120.0% of portfolio
-
State Street Corp Boston, MA118KShares$88,3380.0% of portfolio
-
Northern Trust Corp Chicago, IL94.9KShares$71,1600.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny90.5KShares$67,8720.0% of portfolio
-
Black Rock Inc. New York, NY70.5KShares$52,8980.0% of portfolio
Latest Institutional Activity in MLSS
Top Purchases
Top Sells
About MLSS
Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
Insider Transactions at MLSS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 23
2024
|
Neal I Goldman Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,127
+1.23%
|
$0
$0.55 P/Share
|
|
Apr 22
2024
|
Neal I Goldman Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,065
+3.11%
|
$0
$0.54 P/Share
|
|
Dec 11
2023
|
Neal I Goldman Director |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+6.88%
|
$0
$0.63 P/Share
|
|
Oct 23
2023
|
Giandomenico Trombetta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,400
-0.01%
|
$0
$0.97 P/Share
|
|
Oct 19
2023
|
Giandomenico Trombetta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
20,600
-0.1%
|
$0
$0.95 P/Share
|
|
Oct 18
2023
|
Giandomenico Trombetta Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,000
-0.03%
|
$0
$0.92 P/Share
|
|
Aug 01
2023
|
Peter J Milligan President |
BUY
Grant, award, or other acquisition
|
Direct |
46,296
+27.12%
|
$46,296
$1.08 P/Share
|
|
Jun 28
2023
|
Leonard Osser Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,360
+2.37%
|
$0
$0.89 P/Share
|
|
Jun 28
2023
|
Benedetta I Casamento Director |
BUY
Grant, award, or other acquisition
|
Direct |
134,831
+33.33%
|
$0
$0.89 P/Share
|
|
Jun 28
2023
|
Neal I Goldman Director |
BUY
Grant, award, or other acquisition
|
Direct |
134,831
+7.92%
|
$0
$0.89 P/Share
|
|
Jun 28
2023
|
Giandomenico Trombetta Director |
BUY
Grant, award, or other acquisition
|
Direct |
112,360
+1.08%
|
$0
$0.89 P/Share
|
|
May 17
2023
|
Jan Adriaan Haverhals President |
BUY
Grant, award, or other acquisition
|
Direct |
165,841
+34.17%
|
$165,841
$1.01 P/Share
|
|
Dec 19
2022
|
Neal I Goldman Director |
BUY
Open market or private purchase
|
Direct |
55,326
+3.72%
|
$0
$0.5 P/Share
|
|
Dec 19
2022
|
Leslie Bernhard Director |
SELL
Open market or private sale
|
Direct |
79,268
-50.0%
|
$0
$0.5 P/Share
|
|
Nov 23
2022
|
Leslie Bernhard Director |
SELL
Open market or private sale
|
Direct |
14,358
-8.3%
|
$0
$0.64 P/Share
|
|
Nov 23
2022
|
Neal I Goldman Director |
BUY
Open market or private purchase
|
Direct |
45,095
+3.17%
|
$0
$0.62 P/Share
|
|
Nov 22
2022
|
Neal I Goldman Director |
BUY
Open market or private purchase
|
Direct |
107
+0.01%
|
$0
$0.62 P/Share
|
|
Nov 21
2022
|
Neal I Goldman Director |
BUY
Open market or private purchase
|
Direct |
54,798
+3.95%
|
$0
$0.63 P/Share
|
|
Jun 16
2022
|
Neal I Goldman Director |
BUY
Open market or private purchase
|
Direct |
9,720
+0.81%
|
$0
$0.75 P/Share
|
|
Jun 15
2022
|
Neal I Goldman Director |
BUY
Open market or private purchase
|
Direct |
5,270
+0.44%
|
$0
$0.8 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 744K shares |
|---|
| Sale (or disposition) back to the issuer | 25K shares |
|---|